Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00597896 · ClinicalTrials.gov registry record · Phase 4
Cognitive Enhancement in Bipolar Disorder
A Phase 4 study, sponsored by Northwell Health.
- Completed
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
NCT00597896 is a Phase 4 study that has completed, run by Northwell Health. The registered enrollment target is 50 participants.
The verdict
NCT00597896, a Phase 4 study, has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to examine whether the medication pramipexole (Mirapex) may be able to improve cognitive problems (i.e. difficulties with thinking, memory, and concentration) that may be associated with bipolar disorder.
Interventions
- DRUG pramipexole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2005-10 |
| Est. Completion | 2011-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00597896
The ClinicalTrials.gov registry entry for NCT00597896 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which pramipexole is the first listed.
NCT00597896 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00597896 about?
NCT00597896 is a clinical study titled "Cognitive Enhancement in Bipolar Disorder". The purpose of this study is to examine whether the medication pramipexole (Mirapex) may be able to improve cognitive problems (i.e. difficulties with thinking, memory, and concentration) that may be associated with bipolar disorder.
What is the current status of trial NCT00597896?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2005-10. Estimated completion is 2011-04.
What interventions are being tested in trial NCT00597896?
The interventions under investigation include: pramipexole (DRUG).
Who is sponsoring clinical trial NCT00597896?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.